Drug Profile
Perospirone
Alternative Names: Lullan; SM 9018Latest Information Update: 04 Nov 2018
Price :
$50
*
At a glance
- Originator Dainippon Sumitomo Pharma
- Developer Mitsubishi Tanabe Pharma Corporation; Sumitomo Dainippon Pharma
- Class Antipsychotics; Isoindoles; Small molecules; Thiazoles
- Mechanism of Action Dopamine D2 receptor antagonists; Serotonin 2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Schizophrenia
Most Recent Events
- 19 Jun 2014 Dainippon Sumitomo Pharma is now called Sumitomo Dainippon Pharma
- 01 Oct 2007 Mitsubishi Pharma Corporation has merged with Tanabe Seiyaku to form Mitsubishi Tanabe Pharma Corporation
- 01 Oct 2005 Sumitomo Pharmaceuticals has merged with Dainippon Pharmaceutical to form Dainippon Sumitomo Pharma